Neurovascular Devices/Interventional Neurology Market

Neurovascular Devices/Interventional Neurology Market by Product (Embolic Coils, Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices, Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global Forecasts to 2021

Report Code: MD 1310 Feb, 2017, by marketsandmarkets.com

[193 Pages Report] The neurovascular devices market is expected to reach USD 2.62 billion by 2021 from USD 1.74 billion in 2016, at a CAGR of 8.6% from 2016 to 2021. Major factors driving the growth of this market include growing target patient population, ongoing product development & commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets, and growing market demand for effective neurovascular devices. Moreover, increasing number of researches in the field of neurovascular therapies, rising demand for minimally invasive neurosurgical procedures, and increasing awareness among neurosurgeons about minimally invasive surgical procedures provide significant growth opportunities in the market. However, stringent regulatory scenario and dearth of skilled neurosurgeons may hinder the growth of this market during the forecast period.

Market Dynamics

Drivers

  • Large target patient population
  • Ongoing product development & commercialization
  • Favorable medical reimbursements
  • Expansion of healthcare infrastructure across emerging markets
  • Growing market demand for effective neurovascular devices

Restraints

  • Stringent regulatory scenario
  • Dearth of skilled neurosurgeons

Opportunities

  • Increasing number of researches in the field of neurovascular therapies
  • Rising demand for minimally invasive neurosurgical procedures
  • Increasing awareness among neurosurgeons about minimally invasive surgical procedures

Ongoing product development, favorable medical reimbursements and large target patient population are the major drivers for the market.

The neurovascular devices market is witnessing a new phase of product development developments, with the launch of miniaturized neurovascular devices. Commercialization of more effective, technologically advanced, and easy-to-use neurovascular devices helps in better monitoring and treatment of major neurovascular diseases. This has a direct impact on the adoption of neurovascular devices among key end users. For instance, in July 2016, Microport Scientific Corporation (China) received Thailand FDA approval for the commercialization of Willis Intracranial Stent. This intracranial stent is the first stent in China for the treatment of intracranial aneurysm. Moreover, the industry players have also developed flow diversion device named Pipeline Flex and Micro catheter named Apollo Onyx. Technology innovations in neurovascular devices, in terms of efficiency, accuracy, and less risk of trauma plays a major role in increasing adoption of neurovascular devices among the neurosurgeons. Moreover, launching innovative products in the market helps companies gain a competitive advantage and drive the uptake of their products.

Government bodies in various countries across the globe are increasingly recognizing the benefits offered by neurosurgical & interventional neurology products, such as stents, coils, and flow diverters. Owing to this, the availability of medical reimbursements for neurovascular treatment procedures is continuously increasing among mature markets such as the US, Germany, and the UK. For instance, the CPT codes such as 62165, 62160, and 62161 are introduced by the American Medical Association (AMA) for neurovascular procedures that includes neurovascular devices.

The significant volume consumption of neurovascular devices is majorly attributed to the large and rapidly growing patient population base for target diseases across key markets. Also, the increasing adoption of neurovascular devices among the patients is due to the significant benefits offered by the devices such as short time stay at hospital, and less traumatic.

The following are the major objectives of the study

  • To define, describe, and forecast the global neurovascular devices market on the basis of product, disease pathology, and region
  • To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, and opportunities)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for key stakeholders and provide details of the competitive landscape for leading market players
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
  • To strategically profile the key market players and comprehensively analyze their market shares and core competencies2
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, agreements, and collaborations in the neurovascular devices/interventional neurology devices market

During this research study, major players operating in the interventional neurology market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.

Neurovascular Devices/Interventional Neurology Market

To know about the assumptions considered for the study, download the pdf brochure

The neurovascular devices market is consolidated in nature. Major players in this market include Stryker Corporation (US), Medtronic plc (US), Johnson & Johnson (US), Terumo Corporation (Japan), Penumbra, Inc. (US), Abbott Laboratories (US), Merit Medical Systems, Inc. (US), W. L. Gore & Associates, Inc. (US), and MicroPort Scientific Corporation (China), among others. Product approvals, launches, and enhancements were the key strategies adopted by players to grow and expand their presence in the neurovascular devices market.

Major Market Developments:

  • In December 2016, Codman Neuro (a subsidiary of Johnson & Johnson) acquired Pulsar Vascular Inc. (US), this acquisition aimed at the enhancement of product portfolio for hemorrhagic and ischemic stroke.
  • In December 2016, Terumo Corporation signed an agreement with Abbott Laboratories (U.S.) and St. Jude Medical, Inc. (U.S.). The agreement was aimed at acquisition of St. Jude Medical’s Angio-Seal and FemoSeal vascular closure & Abbott’s Vado Steerable Sheath. This agreement helped Terumo Corporation to enhance the product portfolio in minimally invasive entry site management and strengthen its visibility in the U.S. neurovascular and interventional neurology devices market.
  • In July 2016, Medtronic plc launched its Pivox Oblique Lateral Spinal System with Lateral Plate for OLIF25 and Divergence-L Anterior/Oblique Lumbar Fusion System for OLIF51 for the development of OLIF (Oblique Lateral Interbody Fusion) Platform. The OLIF platform is a minimally invasive spine fusion procedures utilized for the placement of an implant into the disc space for anterior column support.
  • In July 2016, Penumbra, Inc. launched ACE 68 Reperfusion Catheter for the treatment of acute ischemic stroke. It includes latest technological advancements to deliver maximum aspiration power for extracting thrombus in acute ischemic stroke patients.
  • In February 2015, Terumo Corporation announced the establishment of its R&D center in Southern California (U.S.) with an investment of USD 84.0 million (~JPY 10.0 billion). The R&D center will commence operations in 2017, and is mandated to focus on R&D programs related to coronary and peripheral interventional therapies (including neurovascular surgeries).

Target Audience:

  • Original Equipment Manufacturers (OEMs)
  • Product Sales and Distribution Companies
  • Healthcare Service Providers (Hospitals and Surgical Centers)
  • Non-government Organizations
  • Government Regulatory Authorities
  • Research Laboratories and Academic Institutes
  • Clinical Research Organizations (CROs)
  • Research and Development Companies
  • Market Research and Consulting Firms

Scope of the Report

This report categorizes the neurovascular devices market into the following segments and sub-segments.

Neurovascular Devices Market, by Product

  • Aneurysm Coiling & Embolization Devices
  • Embolic Coils
  • Bare Detachable Coils
  • Coated Detachable Coils
  • Flow Diversion Devices
  • Liquid Embolic Agents
  • Cerebral Balloon Angioplasty and Stenting Systems
  • Carotid Artery Stents
  • Embolic Protection Systems
  • Distal Filter Devices
  • Balloon Occlusion Devices
  • Support Devices
  • Microcatheters
  • Microguidewires
  • Neurothrombectomy Devices
  • Clot Retrieval Devices
  • Suction and Aspiration Devices
  • Snares

Neurovascular Devices Market, by Disease Pathology

  • Ischemic Strokes
  • Cerebral Aneurysms
  • Arteriovenous Malformation and Fistulas
  • Other Disease pathology

Neurovascular Devices Market, by Region

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • RoE (Rest of Europe)
  • Asia Pacific
  • Japan
  • China
  • India
  • RoAPAC (Rest of Asia Pacific)
  • Rest of the World (LATAM, the Middle East, and Africa)

Critical Questions which the report answers:

  • What are the emerging technologies for interventional neurology treatment ecosystem? What is their growth potential during next decade?
  • What are the key revenue generating pockets for major neurovascular devices market; and their future potential during next decade?
  • How competitive landscape is evolving in minimally invasive/interventional neurology devices industry?

Available Customizations

  • With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs. The following customization options are available for the report:

Company Information

  • Product matrix which gives the detailed comparison of the product portfolios of the top five companies

Geographical Analysis

  • Further breakdown of the Rest of World market size into Latin America, Middle East, and Africa

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

The neurovascular devices market is expected to reach USD 2.62 billion by 2021 from USD 1.74 billion in 2016, at a CAGR of 8.6% from 2016 to 2021. The market is mainly driven by factors such as growing target patient population, ongoing product development and commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets, and growing market demand for effective neurovascular devices.

Neurovascular/interventional neurology devices are used to treat several neurovascular diseases (including aneurysms, arteriovenous malformations, atherosclerosis, and moyamoya disease) that affect the central nervous system as well as the blood vascular system associated with it. As compared to conventional neurovascular devices such as neurosurgery and radiosurgery devices, interventional neurology devices offer a minimally invasive mode of treatment.

On the basis of product, the neurovascular devices market is segmented into the neurovascular devices market is segmented into aneurysm coiling and embolization devices, cerebral balloon angioplasty and stenting systems, support devices, and neurothrombectomy devices. The aneurysm coiling and embolization devices segment, by type, is segmented into embolic coils, flow diversion devices, and liquid embolic agents. The aneurysm coiling and embolization devices segment is expected to account for the largest market share in 2016. This can primarily be attributed to the growing end-user preference for minimally invasive neurosurgical procedures and increasing market availability of embolic coils for neurovascular treatment.

On the basis of disease pathology, the neurovascular devices market is segmented into ischemic strokes, cerebral aneurysm, arteriovenous malformations & fistulas, and other diseases. The ischemic stroke segment is expected to grow at the highest CAGR during the forecast period due to the growing incidence of ischemic stroke across the globe and increasing patient preference for minimally invasive surgeries.

Neurovascular Devices/Interventional Neurology Market

The market is dominated by North America, followed by Europe, Asia Pacific, and the Rest of the World. North America is expected to dominate the market in 2016. Asia Pacific is expected to grow at a highest CAGR during the forecast period. Factors such as presence of a large patient population base for target diseases, rising awareness among neurosurgeons related to the benefits offered by interventional neurology devices, and ongoing government initiatives to modernize & expand healthcare infrastructure are expected to drive market growth in Asia Pacific. Moreover, the growing focus of major players in this region is expected to boost the neurovascular devices market in Asia Pacific.

Ischemic stroke forms the fastest growing disease pathology segment.

Ischemic Strokes

Ischemic strokes are caused when the neurovascular blood flow to the brain or spinal cord is blocked. Ischemic strokes are increasingly being treated by minimally invasive neurovascular procedures (including diagnostic angiography, cerebral balloon angioplasty, stent placement, embolization, and coiling) owing to growing patient preference for these procedures). The market for this segment is mainly driven by growing incidence of ischemic stroke across the globe and increasing patient preference for minimally invasive & affordable therapeutic alternatives.

Cerebral Aneurysms

Cerebral aneurysms are marked by abnormal focal dilation in the neurovascular system, which results in the weakening of the inner muscular layer of the blood vessel wall. This may lead to rupture of the artery wall, leading to local hemorrhage. This segment is expected to witness growth due to the ongoing technological advancements in minimally invasive treatments and growing target patient population worldwide.

Arteriovenous Malformation and Fistulas

Arteriovenous malformation (AVM) is a specific cerebrovascular disease that leads to disrupted blood flow due to poorly formed blood vessels. The neurovascular devices market for arteriovenous malformation and fistulas is expected to witness positive growth in the coming years, mainly due to the recent product innovations in the field of embolic coiling, growing market demand for non-invasive treatment across major markets, and continuous reductions in product costs.

Other Disease Pathologies

Neurovascular devices are used for the minimally invasive treatment of several other cerebrovascular diseases such as carotid artery stenosis, cavernous malformation, and Moyamoya disease, among others. These diseases are treated by carotid angioplasty and stenting (carotid artery stenosis), microsurgical resections (cerebral cavernous malformations), and cerebral bypass procedures (Moyamoya disease). Increasing number of minimally invasive procedures worldwide, growing patient preference for minimally invasive therapeutic procedures, and growing disease burden for target diseases are the factors that drive the demand growth of neurovascular devices used for the treatment of other disease pathologies.

Critical questions the report answers:

  • What are the emerging technologies for interventional neurology treatment ecosystem? What is their growth potential during next decade?
  • What are the key revenue generating pockets for major neurovascular devices market; and their future potential during next decade?
  • How competitive landscape is evolving in minimally invasive/interventional neurology devices industry?

Across mature markets, the developmental pipeline for interventional neurology products is affected mainly because of the pricing pressure faced by key product manufacturers resulting from unsupportive government reforms undertaken in the last three years. Moreover, certain legislations implemented by the government of emerging markets such as China and India results in increased operational costs and that negatively affect the cash flow of medical device companies across major healthcare markets worldwide. Several reforms have been undertaken by the Indian and Chinese government in the last few years. For instance, In January 2016, the Indian government increased import duties on medical devices (including interventional neurology products) from 5% to 7.5% of the overall device cost. Additionally, in January 2016, the Indian government levied a 4% additional customs duty on medical devices that were previously exempted. In addition, from 2015 onwards, medical device manufacturers are mandated to register with the State Food and Drug Administration (China) prior to entering the Chinese market.

Furthermore, the neurovascular devices/ interventional neurology market is hampered due to the dearth of skilled neurosurgeons. The complications in the treatment of unruptured aneurysms include operative morbidity, induced hypertension, hypervolemia, and silent thromboembolic events. Surgical clipping is an important therapeutic alternative to treat cerebral aneurysms. However, mature markets such as the US, Germany, and Japan have only a limited number of neurosurgeons that possess the required skill and experience to perform surgical clipping or endoscopy to treat complex cerebral aneurysms. In terms of providing training and skill development, healthcare providers across these markets have not been able to match the ongoing technological advancements and the expansion of the patient base.

Key players in the neurovascular devices market include Stryker Corporation (US), Medtronic plc (US), Johnson & Johnson (US), Terumo Corporation (Japan), Penumbra, Inc. (US), Abbott Laboratories (US), Merit Medical Systems, Inc. (US), W. L. Gore & Associates, Inc. (US), and MicroPort Scientific Corporation (China), among others.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Opportunity Indicators
           2.2.1 Target Disease Prevalence
           2.2.2 Rising Geriatric Population
           2.2.3 Number of Hospitals and Surgical Centers
           2.2.4 Healthcare Expenditure
           2.2.5 Increasing Clinical Research
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Research Assumptions
           2.5.1 Assumptions

3 Executive Summary (Page No. - 35)

4 Premium Insights (Page No. - 40)
    4.1 Neurovascular Devices Market Overview
    4.2 Global Interventional Neurology Product Market, By Region (2016 vs 2021)
    4.3 Global Neurovascular Devices Market, By Product (2016 vs 2021)
    4.4 Global Neurovascular Devices Market for Disease Pathology, By Region (2016-2021)
    4.5 Neurovascular DevicesMarket, By Country (2016 vs 2021)

5 Market Overview (Page No. - 45)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Key Market Drivers
                    5.2.1.1 Large Target Patient Population
                    5.2.1.2 Ongoing Product Development and Commercialization
                    5.2.1.3 Favorable Medical Reimbursements
                    5.2.1.4 Expansion of Healthcare Infrastructure Across Emerging Markets
                    5.2.1.5 Growing Market Demand for Effective Neurovascular Devices
           5.2.2 Key Market Restraints
                    5.2.2.1 Stringent Regulations
                    5.2.2.2 Dearth of Skilled Neurosurgeons
           5.2.3 Key Market Opportunities
                    5.2.3.1 Increasing Research Activities in the Field of Neurovascular Therapies
                    5.2.3.2 Rising Demand for Minimally Invasive Neurosurgical Procedures
    5.3 Ongoing Clinical Studies
           5.3.1 Embolization Coiling Procedures
           5.3.2 Carotid Artery Stenting Procedures
           5.3.3 Embolic Protection Procedures
           5.3.4 Flow Diversion Procedures
           5.3.5 Supporting Techniques
           5.3.6 Neurothrombectomy Procedures

6 Industry Insights (Page No. - 74)
    6.1 Introduction
    6.2 Supply Chain Analysis
    6.3 Porter’s Five Forces Analysis
    6.4 Industry Trends
           6.4.1 Increasing Awareness Among Surgeons About Benefits of Stereotactic Framework Procedures in Neurosurgeries
           6.4.2 Channel Optimization

7 Neurovascular Devices Market, By Product (Page No. - 78)
    7.1 Introduction
    7.2 Aneurysm Coiling & Embolization Devices
           7.2.1 Embolic Coils
                    7.2.1.1 Bare Detachable Coils
                    7.2.1.2 Coated Detachable Coils
           7.2.2 Flow Diversion Devices
           7.2.3 Liquid Embolic Agents
    7.3 Cerebral Balloon Angioplasty and Stenting Systems
           7.3.1 Carotid Artery Stents
           7.3.2 Embolic Protection Systems
                    7.3.2.1 Distal Filter Devices
                    7.3.2.2 Balloon Occlusion Devices
    7.4 Support Devices
           7.4.1 Microcatheters
           7.4.2 Microguidewires
    7.5 Neurothrombectomy Devices
           7.5.1 Clot Retrieval Devices
           7.5.2 Suction and Aspiration Devices
           7.5.3 Snares

8 Global Neurovascular Devices Market, By Disease Pathology (Page No. - 110)
    8.1 Introduction
    8.2 Ischemic Strokes
    8.3 Cerebral Aneurysms
    8.4 Arteriovenous Malformation and Fistulas
    8.5 Other Disease Pathologies

9 Global Neurovascular Devices Market, By Region (Page No. - 117)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 France
           9.3.3 U.K.
           9.3.4 Rest of Europe
    9.4 Asia-Pacific
           9.4.1 Japan
           9.4.2 China
           9.4.3 India
           9.4.4 Rest of Asia-Pacific
    9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. - 144)
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Scenario
     10.4 Recent Developments
             10.4.1 Product Launches
             10.4.2 Strategic Acquisitions
             10.4.3 Expansions
             10.4.4 Agreements and Collaborations
             10.4.5 Other Developments

11 Company Profiles (Page No. - 153)
(Business Overview, Products Offered, Key Insights, Recent Developments, MnM View)*
     11.1 Introduction
             11.1.1 Geographic Benchmarking
     11.2 Stryker Corporation
     11.3 Medtronic PLC
     11.4 Johnson & Johnson
     11.5 Terumo Corporation
     11.6 Penumbra, Inc.
     11.7 Boston Scientific Corporation
     11.8 Microport Scientific Corporation
     11.9 Merit Medical Systems, Inc.
     11.10 W.L. Gore & Associates, Inc.
     11.11 Abbott Laboratories

*Details on Business Overview, Products Offered, Key Insights, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 182)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports
     12.7 Author Details


List of Tables (100 Tables)

Table 1 Embolization Coils: Ongoing Clinical Trials (As of December 2016)
Table 2 Carotid Stents: Ongoing Clinical Trials (As of December 2016)
Table 3 Distal Filter and Balloon Occlusion Catheters: Ongoing Clinical Trials (As of December 2016)
Table 4 Flow Diversion Devices: Ongoing Clinical Trials (As of December 2016)
Table 5 Microcatheters: Ongoing Clinical Trials (As of December 2016)
Table 6 Clot Retrieval, Suction, and Aspiration Devices: Ongoing Clinical Trials (As of December 2016)
Table 7 Global Interventional Neurology Market Size, By Product, 2014–2021 (USD Million)
Table 8 Global Interventional Neurology Market Size, By Region, 2014–2021 (USD Million)
Table 9 Global Interventional Neurology Market Size, By Product, 2014–2021 (Units)
Table 10 Global Aneurysm Coiling & Embolization Devices Market Size, By Type, 2014–2021 (USD Million)
Table 11 Global Aneurysm Coiling & Embolization Devices Market Size, By Type, 2014–2021 (Units)
Table 12 Global Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014–2021 (USD Million)
Table 13 Embolic Coils: Global Aneurysm Coiling & Embolization Devices Market Size, By Type, 2014–2021 (USD Million)
Table 14 Embolic Coils: Global Aneurysm Coiling & Embolization Devices Market Size, By Type, 2014–2021 (Units)
Table 15 Embolic Coils: Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014–2021 (USD Million)
Table 16 Bare Detachable Coils: Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014–2021 (USD Million)
Table 17 Bare Detachable Coils: Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014–2021 (Units)
Table 18 Coated Detachable Coils: Global Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014–2021 (USD Million)
Table 19 Coated Detachable Coils: Global Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014–2021 (Units)
Table 20 Flow Diversion Devices: Global Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014–2021 (USD Million)
Table 21 Flow Diversion Devices: Global Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014–2021 (Units)
Table 22 Liquid Embolic Agents: Global Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014–2021 (USD Million)
Table 23 Liquid Embolic Agents: Global Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014–2021 (Units)
Table 24 Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 25 Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Type, 2014–2021 (Units)
Table 26 Global Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Region, 2014–2021 (USD Million)
Table 27 Carotid Artery Stents: Global Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Region, 2014–2021 (USD Million)
Table 28 Carotid Artery Stents: Global Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Region, 2014–2021 (Units)
Table 29 Embolic Protection Systems: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 30 Embolic Protection Systems: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Type, 2014–2021 (Units)
Table 31 Embolic Protection Systems: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Region, 2014–2021 (USD Million)
Table 32 Distal Filter Devices: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Region, 2014–2021 (USD Million)
Table 33 Distal Filter Devices: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Region, 2014–2021 (Units)
Table 34 Balloon Occlusion Devices: Embolic Protection Systems Market Size, By Region, 2014–2021 (USD Million)
Table 35 Balloon Occlusion Devices: Embolic Protection Systems Market Size, By Region, 2014–2021 (Units)
Table 36 Support Devices: Interventional Neurology Market Size, By Type, 2014–2021 (USD Million)
Table 37 Support Devices: Global Interventional Neurology Market Size, By Type, 2014–2021 (Units)
Table 38 Support Devices: Interventional Neurology Market Size, By Region, 2014–2021 (USD Million)
Table 39 Microcatheters: Neurovascular Support Devices Market Size, By Region, 2014–2021 (USD Million)
Table 40 Microcatheters: Neurovascular Support Devices Market Size, By Region, 2014–2021 (Units)
Table 41 Microguidewires: Neurovascular Support Devices Market Size, By Region, 2014–2021 (USD Million)
Table 42 Microguidewires: Neurovascular Support Devices Market Size, By Region, 2014–2021 (Units)
Table 43 Global Neurothrombectomy Devices Market Size, By Type, 2014–2021 (USD Million)
Table 44 Global Neurothrombectomy Devices Market Size, By Type, 2014–2021 (Units)
Table 45 Global Neurothrombectomy Devices Market Size, By Region, 2014–2021 (USD Million)
Table 46 Clot Retrievers: Global Neurothrombectomy Devices Market Size, By Region, 2014–2021 (USD Million)
Table 47 Clot Retrievers: Global Neurothrombectomy Devices Market Size, By Region, 2014–2021 (Units)
Table 48 Suction & Aspiration Devices: Global Neurothrombectomy Devices Market Size, By Region, 2014–2021 (USD Million)
Table 49 Suction & Aspiration Devices: Global Neurothrombectomy Devices Market Size, By Region, 2014–2021 (Units)
Table 50 Snares: Global Neurothrombectomy Devices Market Size, By Region, 2014–2021 (USD Million)
Table 51 Snares: Global Neurothrombectomy Devices Market Size, By Region, 2014–2021 (Units)
Table 52 Disease Pathology: Global Neurovascular Devices Market Size, 2014–2021 (USD Million)
Table 53 Disease Pathology: Global Neurovascular Devices Market Size, By Region, 2014–2021 (USD Million)
Table 54 Ischemic Strokes Pathology: Global Neurovascular Devices Market Size, By Region, 2014–2021 (USD Million)
Table 55 Cerebral Aneurysms Pathology: Global Interventional Neurology Market Size, By Region, 2014–2021 (USD Million)
Table 56 Arteriovenous Malformation and Fistulas Pathology: Global Interventional Neurology Market Size, By Region, 2014–2021 (USD Million)
Table 57 Other Disease Pathologies: Global Interventional Neurology Market Size, By Region, 2014–2021 (USD Million)
Table 58 Global Interventional Neurology Market Size, By Region, 2014–2021 (USD Million)
Table 59 North America: Interventional Neurology Market Size, By Country, 2014–2021 (USD Million)
Table 60 North America: Interventional Neurology Market Size, By Product, 2014–2021 (USD Million)
Table 61 North America: Aneurysm Coiling and Embolization Devices Market Size, By Product , 2014–2021 (USD Million)
Table 62 North America: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Product, 2014–2021 (USD Million)
Table 63 North America: Support Devices Market Size, By Product, 2014–2021 (USD Million)
Table 64 North America: Neurothrombectomy Devices Market Size, By Product, 2014–2021 (USD Million)
Table 65 North America: Neurovascular Devices Market Size, By Disease Pathology, 2014–2021 (USD Million)
Table 66 U.S.: Interventional Neurology Market Size, By Product, 2014–2021 (USD Million)
Table 67 Canada: Neurovascular Devices Market Size, By Product, 2014–2021 (USD Million)
Table 68 Europe: Interventional Neurology Market Size, By Country, 2014–2021 (USD Million)
Table 69 Europe: Neurovascular Devices Market Size, By Product, 2014–2021 (USD Million)
Table 70 Europe: Aneurysm Coiling and Embolization Devices Market Size, By Product, 2014–2021 (USD Million)
Table 71 Europe: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Product , 2014–2021 (USD Million)
Table 72 Europe: Support Devices Market Size, By Product , 2014–2021 (USD Million)
Table 73 Europe: Neurothrombectomy Devices Market Size, By Product, 2014–2021 (USD Million)
Table 74 Europe: Neurovascular Devices Market Size, By Disease Pathology, 2014–2021 (USD Million)
Table 75 Germany: Interventional Neurology Market Size, By Product, 2014–2021 (USD Million)
Table 76 France: Interventional Neurology Market Size, By Product, 2014–2021 (USD Million)
Table 77 U.K.: Neurovascular Devices Market Size, By Product, 2014–2021 (USD Million)
Table 78 RoE: Interventional Neurology Market Size, By Product, 2014–2021 (USD Million)
Table 79 Asia-Pacific: Interventional Neurology Market Size, By Country, 2014–2021 (USD Million)
Table 80 Asia-Pacific: Neurovascular Devices Market Size, By Product, 2014–2021 (USD Million)
Table 81 Asia-Pacific: Aneurysm Coiling and Embolization Devices Market Size, By Product, 2014–2021 (USD Million)
Table 82 Asia-Pacific: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Product, 2014–2021 (USD Million)
Table 83 Asia-Pacific: Support Devices Market Size, By Product, 2014–2021 (USD Million)
Table 84 Asia-Pacific: Neurothrombectomy Devices Market Size, By Product, 2014–2021 (USD Million)
Table 85 Asia-Pacific: Neurovascular Devices Market Size, By Disease Pathology, 2014–2021 (USD Million)
Table 86 Japan: Interventional Neurology Market Size, By Product, 2014–2021 (USD Million)
Table 87 China: Neurovascular Devices Market Size, By Product, 2014–2021 (USD Million)
Table 88 India: Interventional Neurology Market Size, By Product, 2014–2021 (USD Million)
Table 89 RoAPAC: Interventional Neurology Market Size, By Product, 2014–2021 (USD Million)
Table 90 RoW: Neurovascular Devices Market Size, By Product, 2014–2021 (USD Million)
Table 91 RoW: Aneurysm Coiling and Embolization Devices Market Size, By Product, 2014–2021 (USD Million)
Table 92 RoW: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Product, 2014–2021 (USD Million)
Table 93 RoW: Support Devices Market Size, By Product, 2014–2021 (USD Million)
Table 94 RoW: Neurothrombectomy Devices Market Size, By Product, 2014–2021 (USD Million)
Table 95 RoW: Interventional Neurology Market Size, By Disease Pathology, 2014–2021 (USD Million)
Table 96 Top Product Launches (2013–2016)
Table 97 Top Strategic Acquisitions (2013–2016)
Table 98 Top Expansions (2013–2016)
Table 99 Top Agreements and Collaborations (2013–2016)
Table 100 Other Developments (2013–2016)


List of Figures (52 Figures)

Figure 1 Global Interventional Neurology Market Segmentation
Figure 2 Research Design
Figure 3 Global Stroke Prevalence, By Country, 2015
Figure 4 Increase in Global Geriatric Population, By Country (2010–2015)
Figure 5 Increase in Proportion of Geriatric Individuals in Overall World Population, By Country (2011–2030)
Figure 6 Percentage Increase in Geriatric Population in Total World Population, By Region (1980-2010 vs 2010–2040)
Figure 7 Global Healthcare Expenditure, By Country (2000 vs 2014)
Figure 8 Global Healthcare Expenditure, By Region (2000 vs 2014)
Figure 9 Global Healthcare Spending Matrix, By Key Market (2014)
Figure 10 Bottom-Up Approach
Figure 11 Top-Down Approach
Figure 12 Data Triangulation
Figure 13 Assumptions of the Research Study
Figure 14 Global Neurovascular Devices Market, By Product (2016 vs 2021)
Figure 15 Global Interventional Neurology Market, By Pathology (2016 vs 2021)
Figure 16 Global Neurovascular Devices Market, By Region (2016 vs 2021)
Figure 17 North America to Dominate Global Interventional Neurology Market During 2016-2021
Figure 18 Growing Target Patient Population to Drive Market Demand for Interventional Neurology Products During 2016-2021
Figure 19 Aneurysm Coiling & Embolization Devices to Dominate Interventional Neurology Market, By Product, Until 2021
Figure 20 Embolic Coils to Contribute the Highest to Interventional Neurology Market, By Product, During 2016-2021 (USD Million)
Figure 21 Ischemic Stroke Segment to Lead Global Neurovascular Devices Market, By Pathology, During 2016-2021
Figure 22 China and India to Be the Fastest Growing Countries in Global Interventional Neurology Market During 2016-2021
Figure 23 Interventional Neurology Market: Drivers, Restraints, Opportunities, and Challenges
Figure 24 Proportion of Geriatric Population to Total World Population, By Country, (2012 vs 2020)
Figure 25 Global Trend in Government Healthcare Expenditure: Developed vs Developing Countries (2010 vs 2014)
Figure 26 Ongoing Clinical Trials in Global Interventional Neurology Market (As of December 2016)
Figure 27 Supply Chain Analysis: Neurovascular Devices Market (As of 2016)
Figure 28 Porter’s Five Forces Analysis (2016): Growing Adoption of Neurovascular Products Translating Into Higher Market Demand
Figure 29 Cerebral Balloon Angioplasty & Stenting Systems to Record Highest Growth During 2016-2021 (USD Million)
Figure 30 Embolic Coils Segment to Lead Aneurysm Coiling and Embolization Devices Market During 2016-2021 (USD Million)
Figure 31 Carotid Artery Stents Segment to Record Highest Growth in Cerebral Balloon Angioplasty & Stenting Systems Market Until 2021 (USD Million)
Figure 32 Microcatheters to Hold Largest Share of Support Devices Segment During 2016-2021 (USD Million)
Figure 33 Clot Retrievers to Record Highest Growth in Neurothrombectomy Devices Market, By Type, During 2016-2021 (USD Million)
Figure 34 Ischemic Stroke to Record Fastest Growth in Interventional Neurology Market, By Disease Pathology, During 2016-2021 (USD Million)
Figure 35 North America to Dominate Global Neurovascular Devices Market for Ischemic Strokes Till 2021 (USD Million)
Figure 36 North America: Neurovascular Devices Market Snapshot
Figure 37 Europe: Interventional Neurology Market Snapshot
Figure 38 Asia-Pacific: Neurovascular Devices Market Snapshot
Figure 39 RoW: Interventional Neurology Market Snapshot
Figure 40 Product Launches & Commercialization the Key Growth Strategy Adopted By Majority of Market Players Between 2013 and 2016
Figure 41 Global Interventional Neurology Market Share, By Key Players (2015)
Figure 42 Growing Number of Product Launches and Enhancements Driving Market Growth
Figure 43 Geographic Revenue Mix of Top Four Players in Global Interventional Neurology Market
Figure 44 Stryker Corporation: Company Snapshot (2015)
Figure 45 Medtronic PLC: Company Snapshot (2015)
Figure 46 Johnson & Johnson: Company Snapshot (2015)
Figure 47 Terumo Corporation: Company Snapshot (2015)
Figure 48 Penumbra, Inc.: Company Snapshot (2015)
Figure 49 Boston Scientific Corporation: Company Snapshot (2015)
Figure 50 Microport Scientific Corporation: Company Snapshot (2015)
Figure 51 Merit Medical Systems, Inc.: Company Snapshot (2015)
Figure 52 Abbott Laboratories: Company Snapshot (2015)


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 1310
Published ON
Feb, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Neurovascular Devices/Interventional Neurology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved